Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2013

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
N-octylpyridin-4-amine
EC Number:
265-019-0
EC Name:
N-octylpyridin-4-amine
Cas Number:
64690-19-3
Molecular formula:
C13H22N2
IUPAC Name:
N-octylpyridin-4-amine
Specific details on test material used for the study:
Characterisation of the Test Item
The test item and the information concerning the test item were provided by the sponsor. All data related to the test item are the responsibility of the sponsor and have not been verified by the test facility.

Name: N-Octyl-4-pyridinamine
Batch No.: 565-083
Molecular Weight:206.33 g/mol
Purity: 100%
Physical State/ Colour: solid / white
Storage Conditions: room temperature
Expiry Date: 09 July 2014
Safety Precautions: The routine hygienic procedures were sufficient to assure personnel health and safety.

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Metabolic activation system:
S9
Test concentrations with justification for top dose:
Experiment I:
0.316, 1.00, 3.16, 10.0, 31.6, 100, 316 and 1000 µg/plate
(for tester strains TA 100, TA 1535, TA 1537 and TA 102)
3.16, 10.0, 31.6, 100,316 and 1000 µg/plate
(only for tester strain TA 98)
Experiment II:
1.58, 5.00, 15.8, 50.0, 158, 500 and 1000 µg/plate
Vehicle / solvent:
DMSO
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
sodium azide
methylmethanesulfonate
other: 2-aminoanthracene, 4-nitro-o-phenylene-diamine

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid

Any other information on results incl. tables

Discussion

The test item N-Octyl-4-pyridinamine was investigated for its potential to induce gene mutations according to the plate incorporation test (experiment I and II) using Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and TA 102.

In two independent experiments several concentrations of the test item were used. Each assay was conducted with and without metabolic activation. The concentrations, including the controls, were tested in triplicate. The following concentrations of the test item were prepared and used in the experiments:

Experiment I:

0.316, 1.00, 3.16, 10.0, 31.6, 100, 316 and 1000 µg/plate

(for tester strains TA 100, TA 1535, TA 1537 and TA 102)

3.16, 10.0, 31.6, 100, 316 and 1000 µg/plate

(only for tester strain TA 98)

Experiment II:

1.58, 5.00, 15.8, 50.0, 158, 500 and 1000 µg/plate

No precipitation of the test item was observed in any tester strain used in experiment I and II (with and without metabolic activation) .

Toxic effects of the test item were noted in all tester strains evaluated in experiment I and II.

In experiment I toxic effects of the test item were observed in tester strain TA 98 at concentrations of 316 µg/plate and higher (with and without metabolic activation) . In tester  strain  TA  100  toxic  effects of  the  test item  were  noted  at  concentrations of

31.6 µg/plate and higher (without  metabolic  activation)  and  at  concentrations  of  100 µg/plate and higher (with metabolic activation). In tester strains TA 1535 and TA 1537 toxic effects of the test item were observed at concentrations of 31.6 µg/plate and higher (without metabolic activation) and at concentrations of 316 µg/plate and higher (with metabolic activation). In tester strain TA 102 toxic effects of the test item were noted at concentrations of 100 µg/plate and higher (without metabolic activation) and at concentrations of 316 µg/plate and higher (with metabolic activation).

In experiment II toxic effects of the test item were noted in all tester strains at concentrations of 158 µg/plate and higher (without metabolic activation) and at concentrations of 500 µg/plate and higher (with metabolic activation).

No biologically relevant increases in revertant colony numbers of any of the five tester strains were observed following treatment with N-Octyl-4-pyridinamine at any concentration level, neither in the presence nor absence of metabolic activation in experiment I and II.

The reference mutagens induced a distinct increase of revertant colonies indicating the validity of the experiments.

Applicant's summary and conclusion

Conclusions:
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, N-Octyl-4-pyridinamine did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used.
Therefore, N-Octyl-4-pyridinamine is considered to be non-mutagenic in this bacterial reverse mutation assay.